Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study (CALIPSO): multicentre, adaptive, double-blind, three-arm, placebo-controlled, non-inferiority trial examining antimicrobial prophylaxis duration in cardiac surgery

Peel, Trisha (Primary Chief Investigator (PCI))
Myles, Paul (Chief Investigator (CI))
McGiffin, David (Chief Investigator (CI))
Smith, Julian (Chief Investigator (CI))
Forbes, Andrew (Chief Investigator (CI))
Marasco, Silvana (Chief Investigator (CI))
Pilcher, David (Chief Investigator (CI))
Stewardson, Andrew (Chief Investigator (CI))
Petrie, Dennis (Chief Investigator (CI))
Peleg, Anton (Chief Investigator (CI))
Wisniewski, Jessica (Associate Investigator (AI))
Russo, Philip (Associate Investigator (AI))
Forster, Sam (Associate Investigator (AI))

Project: Research

Project Description

STREAM 7

Short title	Duration of cardiac antimicrobial prophylaxis on outcomes
Acronym	CALIPSO
Status	Active
Effective start/end date	1/02/22 → 31/05/27

Funding

Department of Health and Aged Care (Australia): A$7,979,999.10

1 Article

Healthcare-associated infections and antimicrobial use at a major referral hospital in Papua New Guinea: a point prevalence survey
Curtis, S. J. (Leading Author), Barnabas, R., Cairns, K. A., Cameron, D., Coghlan, B., Jones, R., Joseph, J., Kali, A., Kep, D., Klintworth, G., Levy, S., Mason, M., Norrie, M., Peel, T., Tamolsaian, G., Telenge, J., Tumu, N., Stewardson, A. J. (Leading Author), Ak, G. (Leading Author) & the COMBAT-AMR group, Jul 2024, In: The Lancet Regional Health - Western Pacific. 48, 9 p., 101120.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

3 Citations (Scopus)